MD simulations indicate Omicron P132H of SARS-CoV-2 Mpro is a potential allosteric mutant involved in modulating the dynamics of catalytic site entry loop-Reference-Cited by-同舟云学术

MD simulations indicate Omicron P132H of SARS-CoV-2 Mpro is a potential allosteric mutant involved in modulating the dynamics of catalytic site entry loop

Published:2024-03 Issue: Volume:262 Page:130077
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Bhat Zahoor Ahmad,Khan Mohd Muzammil,Rehman Ayyub,Iqbal Jawed,Sanjeev B.S.,Madhumalar Arumugam

Publisher

Elsevier BV

Reference60 articles.

1. Conservation of substrate specificities among coronavirus main proteases;Hegyi;J. Gen. Virol.,2002

2. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors;Zhang;Science,2020

3. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19;Owen;Science,2021

4. Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir;Ullrich;Bioorg. Med. Chem. Lett.,2022

5. J.T. Lee, Q. Yang, A. Gribenko, B.S. Perrin, Y. Zhu, R. Cardin, P.A. Liberator, A.S. Anderson, L. Hao, Genetic surveillance of SARS-CoV-2 Mpro reveals high sequence and structural conservation prior to the introduction of protease inhibitor paxlovid, mBio 13 (2022) e0086922. doi:https://doi.org/10.1128/mbio.00869-22.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants;Antiviral Research;2024-10

2. A potential allosteric inhibitor of SARS-CoV-2 main protease (Mpro) identified through metastable state analysis;Frontiers in Molecular Biosciences;2024-09-06

3. Crystal structures of coronaviral main proteases in complex with the non-covalent inhibitor X77;International Journal of Biological Macromolecules;2024-09

4. Molecular insight into binding affinities and blockade effects of selected flavonoid compounds on the PD-1/PD-L1 pathway;RSC Advances;2024